Showing posts with label Caffeine. Show all posts
Showing posts with label Caffeine. Show all posts

Saturday, April 4, 2015

Caffeine in Energy Drinks Have Negative Effect On "Young Hearts"

Caffeine in Energy Drinks Have Negative Effect On "Young Hearts"


Introduction

In a short but crispy written article in the Canadian Journal of Cardiology, authors have presented to masses the life-threatening side-effect that over-consumption of energy drinks (EDs) carry with them. EDs mainly differ from other soft and sports drinks regarding their high caffeine content and their promotion as a means to relieve fatigue and improve physical and cognitive performance. In true chemist langauage, what EDs provide to human body is Caffeine, labeled or in masked form alongwith many other organic molecules such as guarana, ginseng, and taurine in variable quantities, which may generate uncertain interactions.

Authors pointed out that Guarana (Paullinia cupana of the Sapindaceae family) is a Brazilian plant containing “guaranine,” which is nothing more than caffeine, in about twice the concentration of the caffeine found in coffee beans (about 2%-4% caffeine in guarana seeds compared with 1%-2% in coffee beans). Taurine is another such organic molecule that appears in many EDs,  is an amino acid that exerts a number of physiological functions, including cell volume regulation and inhibitory neuromodulation. None of these are studied in depth as to what kind of chemical/biological effects these can produce inside young bodies, other than "pumping" them with energy.

The extent of caffeine overdosage can be understood with the following analogy where a volume of 250 mL of numerous EDs contains 70-80 mg of caffeine, a similar quantity of tea contains about 30 mg and percolated coffee contains approximately 90 mg. Even if caffeine is widely used and generally recognized as safe, serious adverse effects have been reported when consumed in larger doses, especially in children, adolescents, and young adults with anxiety, seizures, agitation, migraines, sleeplessness, dehydration, gastrointestinal problems, arrhythmias, and other cardiac events.

Medical situations reported with EDs

The potential cardiac risk of large consumption of EDs emerged from studies demonstrating that caffeinated energy shots are effective for acutely increasing systolic and diastolic blood pressure, heart rate, and cardiac output. Taking clue from Danish Diet, Cancer, and Health Study where caffeine over-consumption was correlated with the incidence of atrial fibrillation (AF) or flutter in almost 48,000 participants, the authors selected AF cases involving young ones, young adults and EDs. 

To further prove their point, authors have provided following case studies:

1. A 13-year-old adolescent boy experienced acute AF (an uncommon condition in children without structural heart disease) during a soccer training session after ingesting EDs.

2. 2 adolescent boys of 14 and 16 years presented with palpitations or vague chest discomfort after excessive ED consumption; AF was finally seen on an electrocardiogram.

3. Two cases of caffeine-induced ST elevation in 17- and 19-year-old adolescents were also reported after overconsumption of EDs.

Despite the popular belief that EDs are safe and efficacious for adolescents, a recent report demonstrated an association between the consumption of a can (250 mL) of ED daily and an increase in anxiety and depression in young adults under certain circumstances. EDs mixed with alcohol aggrevates such conditions further.

Recommendations

1. 250 mL of an ED per day is safe for most healthy adolescents. 
2. ED consumption before or during sports practice should be avoided. 
3. Adolescents with clinically relevant underlying medical conditions should consult cardiologists before drinking EDs. 
4. Excessive consumption of EDs together with alcohol or other drugs, or both, may lead to adverse effects, including death. 
5. Parents should also be educated to limit overconsumption or abuse of EDs by their children.

Article citation: Sanchis-Gomar, F.; et. al. Energy Drink Overconsumption in Adolescents: Implications for Arrhythmias and Other Cardiovascular Events. CJC 2015 April. DOI: http://dx.doi.org/10.1016/j.cjca.2014.12.019

Thursday, April 2, 2015

Caffeine in Treatment for Alzheimer's Disease

Caffeine in Treatment for Alzheimer's Disease

The cause for most Alzheimer's cases is still mostly unknown except for 1% to 5% of cases where genetic differences have been identified. Several competing hypotheses other than genetics exist trying to explain the cause of the disease:

a. Cholinergic hypothesis:  It proposes that AD is caused by reduced synthesis of the neurotransmitter acetylcholine. The cholinergic hypothesis has not maintained widespread support, largely because medications intended to treat acetylcholine deficiency have not been very effective.

b. Amyloid hypothesis: Amyloid precursor protein (APP) is a protein found widely throughout the body. A fault with the processing of amyloid precursor protein (APP) in the brain leads to the production of a short fragment of APP known as beta-amyloid (ßA). The theory rests on the idea that it is the accumulation of this sticky protein fragment (amyloid plaques) in the brain that triggers the disruption and destruction of nerve cells that causes Alzheimer's disease.

c. Tau hypothesis: In normal cells, tau stabilizes axonal microtubules, which are the tracks for intracellular traffic. In AD, tau becomes abnormally phosphorylated, aggregates into paired helical filaments and loses its ability to maintain the microtubule tracks.This may result first in malfunctions in biochemical communication between neurons and later in the death of the cells.

Hypothesis b and c are favorite among the researchers and drug designers alike. A combination of both amyloid and tau too is being considered as the possible reason to Alzheimer disease. As we lack a complete and true understanding of the causes, the clinical trials of drugs designed for AD never end with a positive hope.

A review published in Journal of Caffeine Research, aims to identify the hypothesized role of caffeine in reducing ßA levels and its link with AD.

Caffeine

Some salient discoveries reported in the review are:

1. Caffeine's hydrophobic nature allows for the rapid absorption through all biological membranes and it can easily cross the blood-brain barrier.
2. Research has demonstrated that caffeine intake may protect against AD, and may also lead to remission of symptoms for those who are already affected.
3. Studies in mice shows that coffee was effective in slowing down or prevent the development of ßA plaques.
4. Alertness and response increases as mild to moderate caffeine is ingested, suggesting a possible role of caffeine in the inactive AD patients.
5. Results from epidemiological studies have also reported that coffee and/or caffeine consumption may reduce AD risk.
6. In a study involving the caffeinated mice category, cerebrum had nearly a 50% reduction in levels of ßA, which is known to accumulate into plaques—the hallmark hypothesis of the cause of AD. 
7. Caffeine reverses cognitive impairment and decreases brain ßA levels in aged AD mice.

However these studies have a few catch to them. Firstly, the experiment's are all on mices, no human subject or trial is reported. Secondly, the intake of coffee, provides many other chemicals including caffeine, so the results can be debated. Moreover, the dosage too has to be determined because excess of caffeine comes with its own problems.

Lastly, a genetic study focusing on ßA toxicity in a transgenic Caenorhabditis elegans AD model revealed that the primary protective component is likely not caffeine, although caffeine alone can show moderate protection.

Article citation: Mohan, A.; et. al. Caffeine as Treatment for Alzheimer's Disease: A Review. Journal of Caffeine Research 2015. DOI:10.1089/jcr.2014.0027. (text and citation therein)